BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6200625)

  • 1. [High dose combination chemotherapy (AAABC) and autologous bone marrow transplantation for non-Hodgkin's lymphoma].
    Takagi S; Mutoh Y; Ohda M; Suda K; Kusumoto K; Motoyoshi K; Sakamoto S; Miura Y; Hirai H; Ozawa K
    Rinsho Ketsueki; 1983 Oct; 24(10):1403-7. PubMed ID: 6200625
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autologous bone marrow transplantation using the AAABC regimen in patients with malignant lymphoma].
    Takagi S; Suda K; Komatsu N; Ohta M; Kanou Y; Kitagawa S; Tsuboyama A; Amemiya Y; Motoyoshi K; Mutoh Y
    Rinsho Ketsueki; 1986 Dec; 27(12):2274-80. PubMed ID: 2437342
    [No Abstract]   [Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.
    Schouten HC; Armitage JO; Klassen LW; Vaughan WP; Bierman PJ; Weisenburger D; Kessinger A
    Bone Marrow Transplant; 1989 Jan; 4(1):119-21. PubMed ID: 2466510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
    Gabarre J; Leblond V; Sutton L; Azar N; Jouan M; Boccaccio C; Gonzalez H; Charlotte F; Gentilini M; Binet JL
    Bone Marrow Transplant; 1996 Dec; 18(6):1195-7. PubMed ID: 8971396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma.
    Scheid C; Pettengell R; Ghielmini M; Radford JA; Morgenstern GR; Stern PL; Crowther D
    Bone Marrow Transplant; 1995 Jun; 15(6):901-6. PubMed ID: 7581089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effects of peripheral blood stem cell transplantation following combination chemotherapy using ranimustine, cytarabine, etoposide and cyclophosphamide for patients with hematological malignancies].
    Yamane T; Ohta T; Kou KR; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
    Gan To Kagaku Ryoho; 1994 May; 21(6):903-6. PubMed ID: 7910450
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelotoxicity due to cancer chemotherapy with special reference to autologous bone marrow transplantation].
    Nakamura S
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1195-202. PubMed ID: 6381786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study.
    Snyder MJ; Johnson DB; Daly MB; Giguere JK; Harman GH; Harden EA; Johnson RA; Leff RS; Mercier RJ; Messerschmidt GL
    Bone Marrow Transplant; 1994 Oct; 14(4):595-600. PubMed ID: 7858534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
    Wu GQ
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):47-51. PubMed ID: 7687533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
    Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of a quadruple combination chemotherapy with ACNU, adriamycin, methotrexate, and prednisolone for patients with non-Hodgkin's lymphoma, who were refractory to VEPA (P) treatment].
    Niitsu H; Fukuda M; Fukuda S; Takatsu H; Nakayama Y; Hirokawa M; Mamiya S; Miura I; Takahashi F; Yoshida K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2585-9. PubMed ID: 6594975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Burke HB
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637756
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Nimer SD; Zelenetz A; Portlock C
    N Engl J Med; 1995 Sep; 333(11):728-9; author reply 730. PubMed ID: 7503899
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation versus chemotherapy in non-Hodgkin's lymphoma.
    Mross K
    N Engl J Med; 1995 Sep; 333(11):728; author reply 730. PubMed ID: 7637757
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful high-dose chemotherapy combined with autologous bone marrow transplantation in a case of refractory follicular lymphoma].
    Nagai T; Hirayama Y; Ohta H; Koyama R; Matsunaga T; Kuga T; Sakamaki S; Niitsu Y
    Rinsho Ketsueki; 1997 Jun; 38(6):513-9. PubMed ID: 9248327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
    McQuaker IG; Haynes AP; Iqbal A; Russell NH
    Bone Marrow Transplant; 1996 Jul; 18(1):263-4. PubMed ID: 8832036
    [No Abstract]   [Full Text] [Related]  

  • 19. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma].
    Yamane T; Hino M; Ohta K; Koh KR; Nakamae H; Aoyama Y; Ota T; Kishida T; Mugitani A; Sannomiya Y; Kamitani T; Takubo T; Tatsumi N
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1547-55. PubMed ID: 11016000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
    Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.